232 related articles for article (PubMed ID: 18234426)
1. Adjuvant whole brain radiotherapy: strong emotions decide but rational studies are needed.
Brown PD; Asher AL; Farace E
Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1305-9. PubMed ID: 18234426
[TBL] [Abstract][Full Text] [Related]
2. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
Corn BW; Moughan J; Knisely JP; Fox SW; Chakravarti A; Yung WK; Curran WJ; Robins HI; Brachman DG; Henderson RH; Mehta MP; Movsas B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):71-8. PubMed ID: 18164829
[TBL] [Abstract][Full Text] [Related]
4. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
[TBL] [Abstract][Full Text] [Related]
5. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
[TBL] [Abstract][Full Text] [Related]
6. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
7. Treatment of brain metastases: review of phase III randomized controlled trials.
Scoccianti S; Ricardi U
Radiother Oncol; 2012 Feb; 102(2):168-79. PubMed ID: 21996522
[TBL] [Abstract][Full Text] [Related]
8. The role of postoperative radiotherapy after resection of a single brain metastasis. Combined analysis of 643 patients.
Nieder C; Astner ST; Grosu AL; Andratschke NH; Molls M
Strahlenther Onkol; 2007 Oct; 183(10):576-80. PubMed ID: 17896090
[TBL] [Abstract][Full Text] [Related]
9. What is the randomised evidence for surgery and stereotactic radiosurgery for patients with solitary (or few) brain metastases?
Roos D
Int J Evid Based Healthc; 2011 Mar; 9(1):61-6. PubMed ID: 21332664
[TBL] [Abstract][Full Text] [Related]
10. Decision analysis of stereotactic radiation surgery versus stereotactic radiation surgery and whole-brain radiation therapy for 1 to 3 brain metastases.
Lester-Coll NH; Dosoretz AP; Yu JB
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):563-8. PubMed ID: 24751412
[TBL] [Abstract][Full Text] [Related]
11. Current management of brain metastases, with a focus on systemic options.
Langer CJ; Mehta MP
J Clin Oncol; 2005 Sep; 23(25):6207-19. PubMed ID: 16135488
[TBL] [Abstract][Full Text] [Related]
12. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
Li J; Bentzen SM; Li J; Renschler M; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
[TBL] [Abstract][Full Text] [Related]
13. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
[TBL] [Abstract][Full Text] [Related]
14. Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
Wong J; Hird A; Zhang L; Tsao M; Sinclair E; Barnes E; Danjoux C; Chow E
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1125-31. PubMed ID: 19231099
[TBL] [Abstract][Full Text] [Related]
15. [Mangement of brain metastases based on EBM].
Narita Y
Gan To Kagaku Ryoho; 2005 Apr; 32(4):463-7. PubMed ID: 15853211
[TBL] [Abstract][Full Text] [Related]
16. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309). In reply to Drs. Larson and Sahgal.
Brown PD; Kee AY; Eshleman JS; Fiveash JB
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):316-7. PubMed ID: 19695444
[No Abstract] [Full Text] [Related]
18. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
[TBL] [Abstract][Full Text] [Related]
19. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
20. Whole-brain radiation therapy of brain metastasis.
Sahgal A; Soliman H; Larson DA
Prog Neurol Surg; 2012; 25():82-95. PubMed ID: 22236670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]